Peptide therapy, decoded.
200+ clinical monographs, interactive dosing calculators, and community reviews — all PubMed-referenced and free to access.
Latest Research & Education
Peptide Angio-3 Attenuates Pulmonary Fibrosis Via Modulation of Coagulation Factor Xa-PAR-1 Signaling Axis
Angio-3, a 10-residue peptide derived from human plasminogen kringle 3, demonstrated significant antifibrotic activity in pulmonary fibrosis models by functioning as a PAR-1 antagonist that disrupts the coagulation factor Xa-PAR-1 signaling axis. The peptide inhibited fibroblast invasion and migration with a favorable safety profile—no adverse effects at 0.5 mg/kg/day and only mild hepatomegaly at supratherapeutic doses.
Guía completa de terapia con péptidos 2026
Guía completa de terapia con péptidos en 2026: mecanismos de acción, péptidos clave (BPC-157, tirzepatida, semorrelina), regulación en España, México, Argentina y Colombia, evidencia clínica actualizada y consideraciones prácticas para prescriptores hispanohablantes.
Antimicrobial Peptides Show Promise as Cancer Therapeutics: A 2026 Systematic Review
A new review in Frontiers in Medicine evaluates antimicrobial peptides (AMPs) as anticancer agents, finding selective cytotoxicity against tumor cells via membrane disruption and apoptosis induction, though clinical evidence remains limited to early-phase trials.
Pemvidutide Achieves MASH Resolution in Phase 2b IMPACT Trial
The Lancet published Phase 2b results for pemvidutide, a dual GLP-1/glucagon agonist, showing significant MASH resolution without worsening fibrosis at 24 weeks. FDA granted Breakthrough Therapy designation in January 2026.
Retatrutide Achieves 28.7% Weight Loss in TRIUMPH-4 Phase 3 Trial
Eli Lilly's triple GIP/GLP-1/glucagon agonist retatrutide achieved an average 28.7% body weight reduction at 68 weeks in the pivotal TRIUMPH-4 trial — the largest weight loss ever reported for any anti-obesity medication in Phase 3.
Son seguros los péptidos: lo que dice la investigación clínica
¿Son seguros los péptidos? Analizamos lo que dice la investigación clínica sobre el perfil de seguridad de los péptidos terapéuticos, incluyendo datos de ensayos publicados en PubMed, regulaciones de la AEMPS, COFEPRIS y ANMAT, y los riesgos reales que debes conocer.
Clinical Calculators & Tools
Calculadora de reconstitución
Calcular unidades de jeringa y dosificación a partir de péptidos liofilizados
Try it →⚖️Calculadora de dosificación por peso corporal
Calcular la dosis en función del peso del paciente y de los protocolos mcg/kg
Try it →⏱️Calculadora de vida media e intervalos de dosificación
Estimar el estado estacionario, los intervalos de dosificación y las ventanas de eliminación
Try it →🔄Conversor de unidades de péptidos
Conversión entre microgramos, miligramos, UI y unidades de jeringa
Try it →Real Experiences from Real UsersNEW
Game-changer for my knee recovery
After 6 weeks of subcutaneous injections, the chronic tendon pain I'd had for 2 years was down to almost nothing. Combined with PT, the results were remarkable.
Verified user · 8 weeks
Steady weight loss, minimal sides
Lost 14 lbs over 3 months on the titration schedule. Nausea was real the first 2 weeks but manageable. Worth it for the appetite control alone.
Verified user · 12 weeks
Best GH stack I've tried
Noticeably better sleep by week 2, improved recovery from training by week 4. Skin quality improved. No water retention like with GHRP-6.
Verified user · 16 weeks
Monographs
Interactive Tools
Languages
Independent
Mantente al Día
Actualizaciones clínicas, noticias de la industria, resúmenes de investigación y lanzamientos de herramientas.
Respetamos tu privacidad. Cancela cuando quieras.